Determination of Diffusion Weighted Magnetic Resonance Imaging Based Biomarkers of Mild Cognitive Impairment in Parkinson’s Disease

This study aims to specify biomarkers of Parkinson's disease mild cognitive impairment (PD-MCI) based on fractional anisotropy (FA) and mean diffusivity (MD) maps obtained from diffusion weighted magnetic resonance imaging (DWMRI). T1 and diffusion weighted MR images collected from 27 cognitive...

Full description

Saved in:
Bibliographic Details
Published in:2017 21st National Biomedical Engineering Meeting (BIYOMUT) pp. i - iv
Main Authors: Kaplan, Ozge Can, Arslan, Dilek Betul, Cengiz, Sevim, Kıcik, Ani, Erdogdu, Emel, Hatay, Gokce Hale, Tufekcioglu, Zeynep, Bilgic, Basar, Hanagasi, Hasmet, Gurvit, Hakan, Demiralp, Tamer, Ulug, Aziz Mufit, Isik, Esin Ozturk
Format: Conference Proceeding
Language:English
Turkish
Published: IEEE 01-11-2017
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study aims to specify biomarkers of Parkinson's disease mild cognitive impairment (PD-MCI) based on fractional anisotropy (FA) and mean diffusivity (MD) maps obtained from diffusion weighted magnetic resonance imaging (DWMRI). T1 and diffusion weighted MR images collected from 27 cognitively normal Parkinson's disease (PD-CN), 32 mild cognitively impaired Parkinson's disease (PD-MCI), and 18 healthy control (HC) volunteers, at a clinical 3T MR scanner, were processed using FMRIB Software Library (FSL)'s toolboxes. Average regional values of FA and MD maps and tract based spatial statistics (TBSS) were utilized to define statistically significant differences between the participant subject groups.
DOI:10.1109/BIYOMUT.2017.8479249